AC-2020-12-1420.R1 – HIV care providers' familiarity, concerns, and attitudes about HIV PrEP in Colombia: insights from the PrEP-Col-Study.

In 2019, Colombia approved the combination of tenofovir disoproxil fumarate/emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP). Therefore, we conducted a situational analysis in HIV-care providers to identify barriers and facilitators for PrEP implementation. A survey was applied to a non-probabi...

Descripción completa

Detalles Bibliográficos

Publicado en:	AIDS Care Vol. 34; no. 11; pp. 1428 - 1435
Autores principales:	Martínez-Cajas, Jorge, Alvarado-Llano, Beatriz, Martínez-Buitrago, Ernesto, Torres-Isasiga, Julian, Arrivillaga, Marcela, Camargo, Pilar, Galindo-Orrego, Ximena, Mueses-Marín, Héctor
Formato:	research tables/charts Journal Article
Publicado:	Taylor & Francis Ltd Nov2022
Acceso en línea:	Ver este registro en EBSCOhost